Table 3.
Comparison of efficacy between the gemcitabine and docetaxel groups
Therapeutic regimen (n=113) | P | ||
---|---|---|---|
Gemcitabine + platinum (n=56), n (%) | Docetaxel + platinum (n=57), n (%) | ||
Treatment response | |||
CR | 1 (1.8) | 1 (1.8) | 0.21 |
PR | 39 (69.6) | 29 (50.9) | |
SD | 9 (16.1) | 13 (22.8) | |
PD | 7 (12.5) | 14 (24.6) | |
RR | 40 (71.4) | 30 (52.6) | 0.04 |
DCR | 49 (87.5) | 43 (75.4) | 0.099 |
CR – Complete remission; PR – Partial remission, SD – Stable disease; PD – Progressive disease; RR – Response rate; DCR – disease control rate